StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Lease Maturity: Year 5 by Year

Lease Maturity: Year 5 ($M) ($M)

Natera Lease Maturity: Year 5: $23.1M in FY2025, up 33.5% from a year earlier.

Latest, FY2025
23.1
Period ended Dec 31, 2025
Change on a year earlier
+33.5%
17.3 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Reported in Form 10-K Note — Leases (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLease Maturity: Year 5 ($M) ($M)Year on yearSource
FY2025Dec 31, 202523.1+33.5%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 202417.3+162.8%Form 10-K (2025-02-28) ↗
FY2023Dec 31, 20236.59-51.8%Form 10-K (2024-02-29) ↗
FY2022Dec 31, 202213.7+6.5%Form 10-K (2023-03-01) ↗
FY2021Dec 31, 202112.8+424.1%Form 10-K (2022-02-25) ↗
FY2020Dec 31, 20202.45+2.1%Form 10-K (2021-02-26) ↗
FY2019Dec 31, 20192.40–Form 10-K (2020-03-02) ↗

Cite this data

StockData. (2026). Natera Lease Maturity: Year 5 ($M), annual FY2019–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/lease-undisc-year5

See every metric in the Natera KPI table. Data updated Nov 2, 2026.